Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06577792
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-08
Brief Title:
Lobectomy-First vs Lymphadenectomy-First for Operable NSCLC LOFTY
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Lobectomy-First Versus Lymphadenectomy-First Surgical Approach on Long-Term Survival in Operable Non-Small Cell Lung Cancer Patients A Prospective Multi-Center Randomized Study
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
LOFTY
Brief Summary:
During the surgery for non-small cell lung cancer NSCLC lymphadenectomy or lobectomy are performed first different surgeons have different choices Oncology textbooks require dissecting distant lymph nodes LNs first and then dissecting nearby LNs According to this requirement thoracic surgeons should first perform lymphadenectomy and then lobectomy Unfortunately there is no high-level evidence to prove which surgical sequence is more beneficial to the long-term survival of NSCLC patients In this multi-center randomized controlled trial RCT patients with stage I-II NSCLC were enrolled as the research object to determine which surgical sequence lymphadenectomy-first vs lobectomy-first is better for the short-term and long-term outcomes in NSCLC patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None